• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Emergent BioSolutions

    Cytovance Biologics

    Flow Sciences

    Alcami

    PCI Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    PCI Pharma Services

    Cytovance Biologics

    Flow Sciences

    Aphena Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    FDA Watch

    Data Integrity: Beyond Electronic Records

    Get your Data Integrity house in order

    Data Integrity: Beyond Electronic Records
    Data Integrity: Beyond Electronic Records
    Figure 1. Example of a Data Map for Testing of a Sample
    Data Integrity: Beyond Electronic Records
    Figure 2. Data Map of the Preparation of Reference Standard Solution
    Tim Rhines, Ph.D., Director, Lachman Consultant Services, Inc.05.05.20
    The global pharmaceutical industry has been grappling with the regulatory agencies’ focus on data integrity for the past several years. Data integrity guidance documents issued by regulatory agencies have resulted in the examination of the lifecycle of data coming from the analytical and microbiological laboratories. For a contract laboratory, reliability and trust in the data delivered to the sponsor are paramount. A contract laboratory cannot afford to be implicated in a breach of data integrity, no matter how small. A breach in data integrity not only impacts the data and standing with regulatory agencies, but also compromises relationships with sponsors, and in turn, the health of the business. The data integrity guidance(s) do not need to be considered an obstacle but a tool to improve the trust in the data. Data integrity is not a new concept: it has been part of science for centuries. However, the technology of today has added complexity to proving that the data is beyond reproach.

    One of the foundational tenets of science that young scientists are introduced to in university studies with respect to data integrity is the consequence of “dry labbing” or falsifying results. Instructors emphasize the importance of accurately recording data by issuing the ultimatum that falsifying laboratory data would be met with immediate failure of the course. As scientists enter the pharmaceutical laboratory work force, the effects of falsifying results become clearer as the impact to patient safety is directly impacted by the laboratory data. In today’s environment, acts that breach data integrity guidance by a laboratory analyst should result in disciplinary action. Each discovered case of data falsification or of an uncontrolled process that could easily allow data falsification, adversely impacts the integrity of the data and degree of trustworthiness in the results from a laboratory.

    The principles that guided the documentation of scientific data in the past, when data was recorded primarily in hardcopy laboratory notebooks, are the same as the ALCOA+ principles used now, there just was no acronym used. These principles and definitions require data to be:1
    • Attributable – Who performed the activity, and when?
    • Legible – Can it be read? Must be human-readable and a permanent record
    • Contemporaneous – Recorded at the time the activity was performed
    • Original – Original record or certified true copy
    • Accurate – Error free
    • Complete – Everything is included, and nothing is missing
    • Consistent – The data should be acquired in a chronological order, with time stamps included for any addition to original data
    • Enduring – Data is on a media that is maintained and protected with an emphasis on ensuring data is readable and available long after it is recorded
    • Available – Records are accessible when needed

    For decades, the documented hardcopy laboratory data in bound notebooks was reviewed, and any discrepancy in the data was easily detectable and could be questioned. However, even with hardcopy data, the validity of the data was directly impacted by the integrity of the bench analyst and laboratory management’s commitment to ensuring the recording of complete and accurate data.

    With the introduction of computerized chromatographic data acquisition systems in 1980s and 1990s, a conundrum was created. Was the printout of the data or the electronic file the raw data? If the raw data was the electronic file, was the electronic file secure from being easily altered? In some systems, the files could be written over, renamed, etc., without any audit trail documenting the action. Subsequently, the integrity assurance of the laboratory data was diminished unless laboratories added configurational or procedural controls over the data acquisition systems.

    Compliance to 21 CFR Part 11 - Electronic Records; Electronic Signatures, has been part of our industry for more than two decades, but data integrity guidances have relatively recently enhanced the control of electronic records. Warning letters that cited data integrity gaps  have emphasized the lack of control of computer systems and associated records. However, the data integrity principles also apply to paper-based records, such as printouts from balances, pH meters, documentation captured on loose forms, and observations written directly into a bound laboratory notebook. While a laboratory can achieve compliance with electronic data record integrity, the job is not complete. Laboratories must find and root out vulnerable data documentation practices beyond electronic records. A useful tool to find areas of vulnerability is data mapping. Data mapping is a type of mapping with an emphasis on the lifecycle of data, considering the following:2
    • Generation and recording of data
    • Processing data into usable information
    • Checking the completeness and accuracy of reported data and processed information
    • Data (or results) being used to make a decision
    • Retaining and retrieval of data which protects it from loss or unauthorized amendment
    • Retiring or disposal of data in a controlled manner at the end of its life
    Figure 1 provides an example of a high-level data map of sample testing, starting with sampling and ending with reporting test results, with a breakdown of one step in the process: sample testing. The map provides the visual assessment of how data is generated, the required supporting records, where data is recorded, and how data is recorded. 


    Figure 1. Example of a Data Map for Testing of a Sample

    Many of the steps/boxes in the sample testing data map can be further detailed to eventually list every document that supports each process. Each of the underlying records must meet ALCOA+ principles. Figure 2 exemplifies how the preparation of the reference standard solution step can be further broken down to list each of the underlying records that support the process of the preparation of the reference standard solution.


    Figure 2. Data Map of the Preparation of Reference Standard Solution

    Each of the supporting records should be assessed to ensure all the records meet the ALCOA+ requirements. For example, the weight data from the balance is commonly printed with the metadata of date, time, and balance ID. However, some older analytical balances allow relatively easy access to the date and time settings which are sent to the printer along with the weight data. In such a case, a procedural control is needed to verify that the time and date was correct when the weight was printed. Similar situations may also be present in other small instruments such as pH meters or Karl Fischer titrators. Integrity of date, time, user, and other metadata can be assured when a laboratory adapts a validated e-notebook system.

    Changes in data lifecycle are inevitable, and when changes are proposed it is important to understand the lifecycle elements for each type of the affected data or record, and ensure controls which are proportionate to data criticality and risk at all stages.2 Data mapping the changes can aid in determining if the change increases the risk on data integrity. For example, in the past the logging of the receipt and use of reference standard may have been recorded on a dedicated form or 3 x 5 card that was kept in a file.

    However, was this document (form or card) tracked? Was the document secure at all times? What is the risk to the products if this document was accidently lost/destroyed? Would an electronic system be better? Not necessarily if the electronic records do not meet the ALCOA+ principles; however, even a bound logbook of the reference standard receipt and use would improve the integrity of the data over a loose form. 

    A new data process may have conveniences over the traditional bound notebook, although if changes are not easily detectable through audit trails, controlled through access control, and accountable to individuals, the new process adversely impacts the integrity of the data. Data mapping would explore these potential shortcomings and allow mitigation to ensure a compliant process.

    Data integrity can impact any stage in the data lifecycle, whether the data is electronic or a hardcopy. Therefore, it is important to understand the lifecycle elements for each type of data or record in terms of criticality and risk. Thoroughly mapping each data acquisition process can be a useful tool to find areas of data integrity risk and a potential risk to products. A map of data acquisition in a laboratory should break down the process so that each step in the map can list out every record supporting each process on the map. Then, each of the records can be assessed individually for the risk to data integrity. 

    References
    1. Pharmaceutical Inspection Convention/Pharmaceutical Inspection Co-operation Scheme. “PIC/S Guidance: Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments”, PI 041-1 (Draft 3), November 30, 2018, available for download from https://picscheme.org/en/publications#selCategory_
    2. European Medicines Agency, “Guidance on good manufacturing practice and good distribution practice: Questions and answers: Data integrity,” August 2016, https://www.ema.europa.eu/en/human-regulatory/research-development/compliance/good-manufacturing-practice/guidance-good-manufacturing-practice-good-distribution-practice-questions-answers#data-integrity-(new-august-2016)-section


    Tim Rhines, Ph.D., Director,
    Lachman Consultant Services, Inc.

    Timothy Rhines is a director in the science and technology practice at Lachman Consultants. He is a seasoned CMC pharmaceutical/biopharmaceutical professional with more than 27 years directing CMC activities, leading analytical chemistry teams, addressing compliance gaps, compliance department leadership with P&L responsibility, implementing process excellence initiatives, developing pharmaceutical product stability operations, and CMC project management. Dr. Rhines has a strong technical background encompassing both small and large molecules. For more information visit www.lachmanconsultants.com.
    Related Searches
    • Information Technology

    Related FDA Watch

    • Information Technology | Regulatory Affairs
      FDA’s Increased Information Transparency

      FDA’s Increased Information Transparency

      ...
      Ricki A. Chase, Lachman Consultants 03.09.18

    • GMPs/GCPs | Information Technology | Inspections | Regulatory Affairs

      Mobile Medical Apps

      There's an FDA guidance for that
      Kyle Sampson and Allison L. Reschovsky, Hunton & Williams LLP 11.13.13

    • Clinical Trials | GMPs/GCPs | Information Technology | Inspections | Regulatory Affairs

      Physician Payment Transparency

      ...
      Kyle Sampson, Hunton & Williams LLP 06.05.13


    • Fill/Finish | Information Technology | Logistics | Serialization | Supply Chain | Validation

      Ending Pedigrees?

      FDA’s proposal to abolish drug pedigree requirements
      D. Kyle Sampson, J.D., and Brian J. Wesoloski, J.D. 10.11.11

    • GMPs/GCPs | Information Technology | Inspections | Regulatory Affairs

      Are State Aggregate Spend Laws Here To Stay?

      State sunshine laws in a post-federal sunshine law world
      D. Kyle Sampson, J.D. 03.07.11

    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • A New Era Of Vaccine And Biologic Drug Development
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    Breaking News
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    What You're Reading on Happi.com
    Three Form Vertical Beauty Alliance
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login